Australia markets open in 6 hours 37 minutes

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
742.50+6.27 (+0.85%)
As of 11:22AM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts2072323
Avg. Estimate10.6110.3143.0441.86
Low estimate5.129.537.5130.06
High estimate13.4911.9545.9349.6
Year ago EPS21.3211.4973.643.04
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1982323
Avg. Estimate3.21B3B11.93B12.55B
Low estimate2.83B2.89B11.42B11.26B
High estimate3.47B3.17B12.23B13.38B
Year ago sales4.95B2.97B16.07B11.93B
Sales growth (year/est)-35.20%1.30%-25.80%5.20%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS18.359.748.849.48
Actual EPS21.3211.499.7711.14
Difference2.971.750.931.66
Surprise %16.20%18.00%10.50%17.50%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate10.6110.3143.0441.86
7 days ago10.6510.4143.0841.71
30 days ago10.3210.6341.2143.44
60 days ago10.3610.3541.2343.21
90 days ago10.659.9843.0543.28
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 days1122
Up last 30 days1852410
Down last 7 daysN/AN/AN/AN/A
Down last 30 days11N/A2
Growth estimatesREGNIndustrySector(s)S&P 500
Current qtr.-50.20%N/AN/AN/A
Next qtr.-10.30%N/AN/AN/A
Current year-41.50%N/AN/AN/A
Next year-2.70%N/AN/AN/A
Next 5 years (per annum)-16.60%N/AN/AN/A
Past 5 years (per annum)28.06%N/AN/AN/A